adenosine diphosphate has been researched along with Recrudescence in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (11.11) | 18.7374 |
1990's | 13 (36.11) | 18.2507 |
2000's | 9 (25.00) | 29.6817 |
2010's | 10 (27.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Dong, K; Liu, L; Rao, Z; Wang, A; Wang, F; Wang, Y; Zhao, X; Zheng, H | 1 |
Adriaenssens, T; Alfonso, F; Byrne, RA; Curzen, N; Dens, J; Desmet, W; Dudek, D; Feldman, LJ; Gershlick, AH; Godschalk, TC; Goodall, AH; Guagliumi, G; Hlinomaz, O; Joner, M; Kastrati, A; Malik, N; Massberg, S; Neumann, FJ; Schulz, C; Sinnaeve, P; Steg, PG; Ten Berg, JM; Trenk, D; Wojdyla, R; Wykrzykowska, JJ; Zaman, AG | 1 |
Bedell, B; Breheny, P; Brown, NW; Bødker, FL; Christensen, K; Eidem, HR; Farrow, EG; Graham, BE; Hallman, M; Hinds, DA; Hu, Y; Huusko, JM; Jacobsson, B; Jiang, PP; Karjalainen, MK; Kingsmore, SF; Litterman, NK; Miller, NA; Muglia, LJ; Murray, JC; Rämet, M; Rokas, A; Russell, L; Ryckman, KK; Teramo, K; Williams, SM; Zhang, G | 1 |
Chernousova, LA; Denisova, TP; Dolotovskaya, PV; Furman, NV; Malinova, LI | 1 |
Cong, YL; Dong, M; Li, J; Sun, B; Wu, C; Yang, L; Zhu, L | 1 |
Clark, T; Hajj-Ali, RA; Hoffman, GS; Langford, C; Major, J; Silverstein, RL; Sun, Z; Zhang, L | 1 |
Ikegami, M; Matsuda, S; Miyashita, Y; Obara, S; Shimizu, M; Sugiyama, N; Takagi, S; Takizawa, S; Yokoyama, J | 1 |
Bagatini, M; Bellé, LP; Correa, M; Mazzanti, CM; Moretto, MB; Morsch, VM; Oliveira, L; Rosa, C; Schetinger, MR; Schmatz, R; Spanevello, RM; Stefanello, N; Thomé, G | 1 |
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giglioli, C; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Valente, S | 1 |
Alessi, MC; Bonnet, JL; Cuisset, T; Fourcade, L; Gaborit, B; Grosdidier, C; Molines, L; Morange, PE; Pankert, M; Quilici, J | 1 |
Abu-Hegazy, M; Azzam, H; El-Mitwalli, A; Gomaa, M; Wasel, Y | 1 |
Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP | 1 |
Beinart, R; Bienart, R; Goldenberg, I; Guetta, V; Hod, H; Matetzky, S; Novikov, I; Pres, H; Savion, N; Shechter, M; Shenkman, B; Varon, D | 1 |
Berti, S; Biagini, A; Clerico, A; Gianetti, J; Maffei, S; Paoli, F; Paradossi, U; Parri, MS; Sbrana, S | 1 |
Barnard, MR; Fox, ML; Frelinger, AL; Furman, MI; Li, Y; Linden, MD; Michelson, AD | 1 |
Daniel, WG; Fateh-Moghadam, S; Garlichs, C; Gawaz, M; Geisler, T; Handschu, R; Htun, P; Langer, H; Sander, D; Stellos, K; Tomandl, B; Walton, K | 1 |
Cleanthis, M; Smout, J; Stansby, G | 1 |
Bareiss, P; Bernhard, N; Desprez, D; Freyssinet, JM; Grunebaum, L; Morel, O; Toti, F | 1 |
Greenfield, JC; Hines, JJ; Holmes, EW; Sabina, RL; Swain, JL | 1 |
Agnelli, G; Callegari, P; Hauert, J; Iorio, A; Parise, P | 1 |
Bozarth, JM; Diemer, M; Forsythe, MS; Mousa, SA; Reilly, TM | 1 |
Bolin, KM; Brace, LD; Helgason, CM; Hoff, JA; Mangat, A; Tortorice, KL; Winkler, SR | 1 |
Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Komamura, K; Minamino, T; Morioka, T; Node, K; Takeda, H | 1 |
Adrie, C; Bloch, KD; Gold, HK; Guerrero, JL; Holt, R; Hurford, WE; Moreno, PR; Semigran, MJ; Zapol, WM | 1 |
Agarwal, AK; Goel, PK; Seth, PK; Shahi, M; Srivastava, S | 1 |
Bentley, R; Bostwick, JS; Dunwiddie, CT; Kasiewski, CJ; Leadley, RJ; McVey, MJ; Perrone, MH; White, FJ | 1 |
Chintagumpala, M; Chow, TW; Hellums, JD; McPherson, PD; Moake, JL; Nolasco, LH; Rice, L; Turner, NA | 1 |
Bode, C; Kohler, B; Kübler, W; Moser, M; Nordt, TK; Peter, K; Ruef, J | 1 |
Barlage, S; Lackner, KJ; Schmitz, G; von Landenberg, C | 1 |
Drueke, T; Gazengel, C; Jacques, C; Kremp, O; Nedellec, J | 1 |
Corbett, RJ; Laptook, AR; Olivares, E; Ruley, J | 1 |
Juvela, S; Kaste, M | 1 |
Dusleag, J; Eber, B; Klein, W; Költringer, P; Luha, O; Rotman, B; Vanhoutte, PM | 1 |
Abe, S; Arima, S; Atsuchi, Y; Hamasaki, S; Maruyama, I; Nomoto, K; Okino, H; Tahara, M; Tanaka, H; Yamaguchi, H | 1 |
Bonaventi, C; Caneschi, S; Finzi, F | 1 |
Davis, JW | 1 |
4 trial(s) available for adenosine diphosphate and Recrudescence
Article | Year |
---|---|
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
Residual prothrombotic status in low responder patients to clopidogrel identified by Vasodilator-Stimulated Phosphoprotein Phosphorylation (VASP) analysis?
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Aged, 80 and over; Biomarkers; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Drug Resistance; Female; Humans; Male; Microfilament Proteins; Middle Aged; Myocardial Ischemia; P-Selectin; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Recurrence; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
[Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
Topics: Adenosine Diphosphate; Adult; Arteriovenous Shunt, Surgical; Blood Coagulation Disorders; Blood Platelet Disorders; Clinical Trials as Topic; Collagen; Dipyridamole; Factor V; Factor VIII; Female; Humans; Long-Term Care; Male; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Recurrence; Renal Dialysis; Thrombosis | 1976 |
Ketanserin prevents early restenosis following percutaneous transluminal coronary angioplasty.
Topics: Adenosine Diphosphate; Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Coronary Disease; Drug Combinations; Epinephrine; Female; Humans; Ketanserin; Male; Middle Aged; Recurrence | 1990 |
32 other study(ies) available for adenosine diphosphate and Recrudescence
Article | Year |
---|---|
High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors; Stroke; Thrombelastography; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombo
Topics: Adenosine Diphosphate; Aged; Biomarkers; Blood Platelets; Coronary Thrombosis; Drug Resistance; Europe; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Recurrence; Registries; Risk Factors; ST Elevation Myocardial Infarction; Stents; Time Factors; Treatment Outcome | 2017 |
Whole exome sequencing reveals HSPA1L as a genetic risk factor for spontaneous preterm birth.
Topics: Adenosine Diphosphate; Case-Control Studies; Cell Line; Exome; Exome Sequencing; Female; Fibroblasts; Finland; Genetic Predisposition to Disease; Genome-Wide Association Study; HSP70 Heat-Shock Proteins; Humans; Infant, Newborn; Male; Models, Molecular; Phosphorylation; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Receptors, Glucocorticoid; Recurrence; Risk Factors; Signal Transduction | 2018 |
[ADP-Induced Recalcified Blood Clotting Time as a Marker of Rethrombosis Risk and Effectiveness of Antiplatelet Therapy in Acute Coronary Syndrome].
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aspirin; Biomarkers; Humans; Male; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Thrombosis; Whole Blood Coagulation Time | 2018 |
Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients.
Topics: Adenosine Diphosphate; Adult; Aged; Alleles; Blood Coagulation; Blood Platelets; China; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Ischemia; Logistic Models; Male; Middle Aged; Mutation; Percutaneous Coronary Intervention; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Precision Medicine; Receptors, Purinergic P2Y12; Recurrence; Thrombelastography; Ticlopidine | 2015 |
The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study.
Topics: Adenosine Diphosphate; Adult; Atherosclerosis; Blood Platelets; Blood Pressure; Carotid Intima-Media Thickness; Cell-Derived Microparticles; Cohort Studies; Demography; Diastole; Female; Granulomatosis with Polyangiitis; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Platelet Aggregation; Recurrence; Regression Analysis; Risk Factors | 2015 |
[Recurrent idiopathic cerebral infarction in a 5-year-old boy, with emphasis on the importance of platelet aggregation analysis for appropriate selection of anti-platelet drugs].
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation Tests; Cerebral Infarction; Child, Preschool; Cilostazol; Collagen; Drug Therapy, Combination; Epinephrine; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Tetrazoles; Ticlopidine; Treatment Outcome | 2009 |
The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients.
Topics: Adenosine Deaminase; Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aged; Antigens, CD; Apyrase; Case-Control Studies; Female; Gene Expression Regulation, Enzymologic; Humans; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Recurrence | 2010 |
High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arachidonic Acid; Cardiovascular Diseases; Chi-Square Distribution; Collagen; Drug Resistance; Drug Therapy, Combination; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome | 2010 |
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Resistance; Follow-Up Studies; Hemorrhage; Humans; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Stents; Ticlopidine | 2011 |
Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Brain Ischemia; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Specimen Handling; Treatment Failure | 2013 |
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Epinephrine; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Prospective Studies; Purinergic P2 Receptor Antagonists; Recurrence; Risk; Smoking; Stents; Ticlopidine; Treatment Outcome | 2004 |
Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Collagen; Coronary Artery Disease; Epinephrine; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Multivariate Analysis; Myocardial Ischemia; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors; Survival Rate; Time Factors | 2006 |
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Clopidogrel; Coronary Artery Disease; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Resistance; Female; Flow Cytometry; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Signal Transduction; Thrombosis; Thromboxane B2; Ticlopidine; Time Factors; Treatment Refusal | 2006 |
Hyperresponsiveness of platelets in ischemic stroke.
Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Biomarkers; Blood Platelets; Brain Ischemia; Collagen; Epinephrine; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Predictive Value of Tests; Recurrence; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Stroke; Time Factors | 2007 |
Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Epinephrine; Humans; Ischemic Attack, Transient; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Recurrence; Stroke; Time Factors | 2008 |
Repetitive episodes of brief ischaemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Coronary Disease; Cytidine Triphosphate; Dogs; Guanosine Triphosphate; Ligation; Myocardium; Perfusion; Phosphocreatine; Purine Nucleotides; Pyrimidine Nucleotides; Recurrence; Uridine Triphosphate | 1984 |
Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Cell Adhesion Molecules; Fibrinogen; Flow Cytometry; Humans; Myocardial Infarction; P-Selectin; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Activation; Platelet Membrane Glycoproteins; Recombinant Proteins; Recurrence; Serotonin; Streptokinase; Thrombin; Thrombolytic Therapy; Thromboxane A2 | 1995 |
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Clinical Protocols; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Fibrinolysis; Hemodynamics; Humans; Male; Mesylates; Models, Cardiovascular; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Recurrence; Streptokinase; Thrombosis | 1994 |
Development of aspirin resistance in persons with previous ischemic stroke.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Brain Ischemia; Cerebrovascular Disorders; Cohort Studies; Collagen; Dose-Response Relationship, Drug; Drug Resistance; Drug Tolerance; Epinephrine; Female; Follow-Up Studies; Humans; Intracranial Embolism and Thrombosis; Male; Platelet Aggregation; Recurrence | 1994 |
Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Animals; Cytosol; Dogs; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Recurrence; Time Factors | 1996 |
Inhaled nitric oxide increases coronary artery patency after thrombolysis.
Topics: Adenosine Diphosphate; Administration, Inhalation; Animals; Bleeding Time; Coronary Thrombosis; Coronary Vessels; Dogs; Female; Male; Nitric Oxide; Platelet Aggregation; Recurrence; Thrombolytic Therapy; Vascular Patency; Vasoconstriction | 1996 |
Platelet aggregability and occurrence of restenosis following coronary angioplasty.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors | 1997 |
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Collagen; Coronary Thrombosis; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Hirudin Therapy; Hirudins; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin; Prothrombin Time; Recombinant Proteins; Recurrence; Safety; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator | 1997 |
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Child; Child, Preschool; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation; Platelet Count; Protein Binding; Purpura, Thrombotic Thrombocytopenic; Recurrence; Ristocetin; von Willebrand Factor | 1998 |
Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombin III; Aspirin; Coronary Vessels; Diabetes Mellitus; Drug Therapy, Combination; Female; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Peptide Fragments; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Platelet Aggregation; Predictive Value of Tests; Prothrombin; Recombinant Proteins; Recurrence; Risk Factors; Smoking; Thrombolytic Therapy; Tissue Plasminogen Activator; Vascular Patency | 1998 |
Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Topics: Adenosine Diphosphate; Animals; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antibody Specificity; Antiphospholipid Syndrome; Autoimmune Diseases; Biomarkers; Blood Coagulation Factors; Blood Platelets; Cattle; Cells, Cultured; Dose-Response Relationship, Immunologic; Endothelium, Vascular; Female; Fibrinogen; Humans; Immunoglobulin G; Intracranial Embolism; Lipopolysaccharides; Lupus Erythematosus, Systemic; Male; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Recurrence; Thrombophilia; Thromboplastin | 2000 |
Blood flow and metabolism during and after repeated partial brain ischemia in neonatal piglets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Animals, Newborn; Brain; Brain Ischemia; Cerebrovascular Circulation; Magnetic Resonance Spectroscopy; Recurrence; Swine | 1992 |
Reduced platelet aggregability and thromboxane release after rebleeding in patients with subarachnoid hemorrhage.
Topics: Adenosine Diphosphate; Adult; Aged; Blood Platelets; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Prognosis; Prospective Studies; Recurrence; Subarachnoid Hemorrhage; Thromboxane B2 | 1991 |
[Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; beta-Thromboglobulin; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Recurrence; Thrombolytic Therapy; Thromboxane B2 | 1990 |
[Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)].
Topics: Adenosine Diphosphate; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Isoxsuprine; Male; Oxazoles; Platelet Aggregation; Recurrence | 1985 |
Severe platelet dysfunction in a man with a normal bleeding time.
Topics: Adenosine Diphosphate; Aged; Blood Cell Count; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Clot Retraction; Collagen; Diagnosis, Differential; Epistaxis; Female; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Norepinephrine; Platelet Adhesiveness; Recurrence | 1974 |